Derek Cogan

Vice President, Chemistry at Volastra Therapeutics - New York, NY, US

Derek Cogan's Contact Details
HQ
N/A
Location
New York,New York,United States
Company
Volastra Therapeutics
Derek Cogan's Company Details
Volastra Therapeutics logo, Volastra Therapeutics contact details

Volastra Therapeutics

New York, NY, US • 20 - 49 Employees
BioTech/Drugs

Volastra Therapeutics, Inc., is developing novel therapies to treat cancer. Launched from the laboratory of Dr. Lewis Cantley, along with Drs. Olivier Elemento and Samuel Bakhoum, Volastra has identified the mechanisms by which CIN drives the formation and proliferation of solid tumors. Following initial evidence that a patient's CIN status is prognostic and that CIN alters cellular and immune response mechanisms and leads to worse overall survival in mouse models, the company is discovering mechanisms and pathways by which CIN modulates disease to develop novel therapeutics.

N/A
Details about Volastra Therapeutics
Frequently Asked Questions about Derek Cogan
Derek Cogan currently works for Volastra Therapeutics.
Derek Cogan's role at Volastra Therapeutics is Vice President, Chemistry.
Derek Cogan's email address is ***@volastratx.com. To view Derek Cogan's full email address, please signup to ConnectPlex.
Derek Cogan works in the Research industry.
Derek Cogan's colleagues at Volastra Therapeutics are Ryan Schulz, Christina Eng, Jacqueline Gonzalez, Kassoum Nacro, Marysol Chu, Joseph Avallone, Michael Arensman and others.
Derek Cogan's phone number is N/A
See more information about Derek Cogan